Reducing the cost of headache medication
- 52 Downloads
Although medication costs make up one of the smallest portions of the overall expense of headache care, it is the segment of expense that often impacts the patient most directly. The advent of triptans marked a major advance in migraine therapy, but their high cost has limited their widespread use. Four options can be considered as potential means to reduce the cost of triptans. These include compulsory licensing, exclusive contracting, over-the-counter availability, and the introduction of generic triptans. Each method impacts the consumer, third-party payer, or pharmaceutical company in a different manner.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.World Health Organization: WHO model list of essential medicines: 15th list. Available at http://www.who.int/medicines/publications. Accessed February 2008.
- 3.Department of Defense Pharmacoeconomic Center: Guidance for the new oral 5-HT receptor agonist (triptan) contract. Available at http://www.pec.ha.osd.mil/Contracts/triptan_contract_guidance.htm. Accessed December 2007.
- 5.On the Pharm: Sumatriptan approved for OTC use in the UK. Available at http://onthepharm.net/2006/05/imigran-imitrex-otc.html. Accessed January 2008.
- 7.Migraenikerforbundet; The Danish Migraine Association: The price of sumatriptan reaches an all time low. Available at http://www.migraeniker.dk/english/index_eng.htm. Accessed November 2008.